Blocking the overactivated PI3K/AKT/mTOR signaling pathway may be a potential target of B. coagulans MZY531 in treating hepatocellular carcinoma because it regulates cell growth and proliferation. The gene discussed is AKT1; the disease is hepatocellular carcinoma.